Altimmune Inc (ALT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
09-2015 | 06-2015 | 03-2015 | 12-2014 | 09-2014 | |
Sales | 1,156 | 1,150 | 7,069 | 1,826 | 963 |
Gross Profit | 1,156 | 1,150 | 7,069 | 1,826 | 963 |
Operating Expenses | 2,814 | 3,114 | 5,908 | 4,450 | 4,959 |
Operating Income | -1,659 | -1,965 | 1,161 | -2,624 | -3,996 |
Interest Expense | 0 | 0 | 25 | 0 | 47 |
Other Income | 349 | -365 | 347 | 8 | -561 |
Pre-tax Income | -1,309 | -2,330 | 1,483 | -2,616 | -4,603 |
Income Tax | 15 | 11 | 20 | 14 | 25 |
Net Income Continuous | -1,325 | -2,341 | 1,463 | -2,629 | -4,628 |
Net Income | $-1,325 | $-2,341 | $1,463 | $-2,629 | $-4,628 |
EPS Basic Total Ops | -6.01 | -12.01 | 6.01 | -12.01 | -24.02 |
EPS Basic Continuous Ops | -6.20 | -11.03 | 6.91 | -13.19 | -23.58 |
EPS Diluted Total Ops | -6.01 | -12.01 | 6.01 | -12.01 | -24.02 |
EPS Diluted Continuous Ops | -6.20 | -11.03 | 6.87 | -13.19 | -23.58 |
EBITDA(a) | $-1,624 | $-1,928 | $1,198 | $-2,587 | $-3,959 |